Morepen Laboratories Limited — Others, 06-08-2025: Appointment

Morepen Laboratories' Board has approved its financial results for the quarter, reporting a consolidated net profit of Rs. 11.41 Cr on total income of Rs. 429.65 Cr. Key decisions include setting a record date for the final dividend, pending shareholder approval. The Board also approved extending the timeframe for hiving off the Medical Devices Business into its subsidiary, Morepen Medipath Limited, via a slump sale. Shareholders will vote on the re-appointment of Mr. Sanjay Suri as Whole-Time Director for three years and the appointment of M/s. PD and Associates as Secretarial Auditor for five years. The company's stake in Dr. Morepen Limited reduced from 80% to 19.94% after share sale and acquisition of Groom Town Private Limited.